|
COQ10B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.106000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.031980E-01 |
| Normal-vs-Stage2 |
2.515800E-02 |
| Normal-vs-Stage3 |
8.460000E-03 |
| Normal-vs-Stage4 |
1.674260E-02 |
| Stage1-vs-Stage2 |
1.352800E-01 |
| Stage1-vs-Stage3 |
9.242400E-02 |
| Stage1-vs-Stage4 |
1.446370E-01 |
| Stage2-vs-Stage3 |
7.867600E-01 |
| Stage2-vs-Stage4 |
9.257600E-01 |
| Stage3-vs-Stage4 |
8.574000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.328100E-02 |
| Normal-vs-AfricanAmerican |
4.251400E-01 |
| Normal-vs-Asian |
1.802610E-01 |
| Caucasian-vs-AfricanAmerican |
5.490000E-01 |
| Caucasian-vs-Asian |
9.273800E-01 |
| AfricanAmerican-vs-Asian |
7.185000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.523400E-03 |
| Normal-vs-Female |
6.642400E-02 |
| Male-vs-Female |
3.235700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.636600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.977940E-03 |
| Normal-vs-Age(61-80Yrs) |
4.618000E-03 |
| Normal-vs-Age(81-100Yrs) |
6.250800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.303200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.248020E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.161600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.523000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.845000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.692800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.185800E-01 |
| Classical-VS-Follicular |
1.121830E-01 |
| Classical-VS-Other |
2.771000E-01 |
| Classical-VS-Normal |
7.824400E-02 |
| Tall-VS-Follicular |
3.017600E-01 |
| Tall-VS-Other |
2.926800E-01 |
| Tall-VS-Normal |
1.921180E-01 |
| Follicular-VS-Other |
7.021400E-01 |
| Follicular-VS-Normal |
1.888140E-02 |
| Other-VS-Normal |
1.383160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.421800E-03 |
| Normal-vs-N1 |
5.652400E-02 |
| N0-vs-N1 |
5.289400E-01 |
|
|
